Following stabilization with a WHO-recommended all-oral MDR-TB regimen and palliative radiotherapy for a progressive metastatic lesion, he was rechallenged with QL1706 (a unified PD-1/CTLA-4 bispecific antibody). The gene discussed is CTLA4; the disease is tuberculosis.